Stryker Corporation

NYSE:SYK

Medical - Devices

Healthcare
$318.15 +3.08%

+$9.29 today

Market cap
$121.12B
Beta
0.79
P/E (TTM)
35.6
EPS (TTM)
$8.72
Dividend yield
1.11%
52W Low $281.00High $404.87

Volume 3.25M

Average 2.49M

SYK Operating Margin

Operating income as a percentage of revenue, showing the profitability of core operations.

Stryker CorporationNYSE: SYK

Operating Margin · Q2 FY2026 · quarter ended Jun 2026

Operating margin widens to 25.2%

Operating margin was 25.2% in Q2 FY2026, up 6.7 pp from a year earlier. On a trailing-twelve-month basis it was 22.0%, up 0.3 pp year over year. Over 3 fiscal years it narrowed by 0.8 pp.

Context

  • Operating margin widened in 2 of the last 3 fiscal years.

What to watch

Whether operating margin reaches the consensus estimate from 20 analysts of 26.9% for the fiscal year ending Dec 2026, up from 19.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
25.2%+9.6 pp QoQ
Last fiscal yearDec 2025
19.5%+3.1 pp YoY
LTMJun 2026
22.0%+0.3 pp YoY
Operating Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.7 pp+5.9 pp-0.8 pp
1 year+3.1 pp+7.5 pp+4.3 pp
3 years-0.8 pp+8.7 pp+9.5 pp
5 years+9.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Operating Margin history

Percent of revenue · from the income statement

Latest · FY2025
19.5%
Year-over-year change
+3.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Operating Margin vs competitors

How SYK compares with its peers on the latest reported figures

  • SYK's LTM Jun 2026 operating margin of 22.0% is the highest of the 11 companies compared; the peer median is 9.4%.
  • Its year-over-year change of +0.3 pp is the 8th highest of 11, against a peer median of +7.9 pp.
  • Over three fiscal years its change of -0.8 pp compares with a peer median of +3.6 pp.
SYK Competitors Peer median
Operating Margin for SYK and competitors
Company Period LTM level YoY 3-year change
SYKStryker CorporationLTM Jun 202622.0% +0.3 pp-0.8 pp
GMEDGlobus Medical, Inc.LTM Jun 202620.8% +10.0 pp-6.0 pp
MDTMedtronic plcLTM Jul 202618.1% +0.2 pp+0.2 pp
ZBHZimmer Biomet Holdings, Inc.LTM Jun 202615.7% -0.4 pp+6.5 pp
SNNSmith & Nephew plcFY202512.9% +1.6 pp+4.3 pp
CNMDCONMED CorporationLTM Mar 202611.2% -2.3 pp+3.6 pp
IARTIntegra LifeSciences Holdings CorporationLTM Mar 20267.5% +7.0 pp-11.2 pp
XTNTXtant Medical Holdings, Inc.LTM Mar 20262.7% +8.9 pp+17.1 pp
ENOVEnovis CorporationLTM Apr 20262.7% +39.1 pp+3.7 pp
OFIXOrthofix Medical Inc.LTM Mar 2026-4.0% +8.9 pp-5.4 pp
ATECAlphatec Holdings, Inc.LTM Mar 2026-7.2% +14.2 pp+31.1 pp
Peer median (excluding SYK) 9.4%+7.9 pp+3.6 pp

Competitors are the stored peer set for SYK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.11B18.45B20.5B22.6B25.12B
Cost of Revenue6.4B7.41B8B8.05B9.05B
Gross Profit10.71B11.04B12.49B14.55B16.07B
Gross Margin62.6%59.8%61.0%64.4%64.0%
Research & Development1.13B1.23B1.29B1.47B1.58B
Selling, General & Admin5.81B6.08B6.92B7.5B8.65B
Operating Expenses6.95B7.31B8.21B10.86B11.18B
Depreciation & Amortization990M998M1.03B1.05B1.19B
EBITDA3.61B4.02B5.06B6.01B6.31B
EBITDA Margin21.1%21.8%24.7%26.6%25.1%
Operating Income3.76B3.73B4.28B3.69B4.89B
Operating Margin22.0%20.2%20.9%16.3%19.5%
Interest Income68M94M75M139M121M
Interest Expense337M337M356M396M607M
Other Income / Expenses(1.48B)(1.05B)(608M)(197M)(375M)
Income Before Tax2.28B2.68B3.67B3.49B4.51B
Pre-Tax Margin13.3%14.5%17.9%15.5%18.0%
Income Tax Expense287M325M508M499M1.27B
Net Income1.99B2.36B3.17B2.99B3.25B
Net Margin11.7%12.8%15.4%13.2%12.9%
EPS (Basic)5.296.238.347.868.49
EPS (Diluted)5.226.178.257.768.40
Weighted Avg Shares377M378.2M379.6M381M382.2M
Weighted Avg Shares (Diluted)382.3M382.2M383.7M385.6M382.2M

Stryker Corporation

NYSE:SYK

Intrinsic Alpha fair value

Locked

Current Price

$318.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.